A dual lumen drainage cannula configured for use in a VA ECMO system includes a first drainage tube having a proximal end, a distal end, and at least one aperture in at least one wall of the first drainage tube proximate to the distal end of the first drainage tube, and a second drainage tube having a proximal end, a distal end, and at least one aperture in at least one wall of the second drainage tube proximate to the distal end of the second drainage tube. The first drainage tube passes through the second drainage tube. The dual lumen drainage cannula also includes a sleeve positioned adjacent to an interior wall of the second drainage tube. The sleeve is formed of a flexible material so as to be expandable and collapsible within the second drainage tube.

The disclosure pertains to a perfusion system that is easy to set-up, use and monitor during a bypass procedure. In some embodiments, the disclosure pertains to a perfusion system in which at least some of the disposable components used with the perfusion system are configured to be able to communicate set-up and/or operational parameters to the perfusion system. In some embodiments, the disclosure pertains to a blood level sensor that can be used to monitor a blood level or volume within a blood reservoir. The blood level sensor may be utilized in an integrated perfusion system in which the disposable components are configured, as noted above, to communicate with the perfusion system. In some embodiments, the blood level sensor may be utilized with a perfusion system lacking communication with disposables.

A centrifugal pump includes a rotating shaft, a pump substrate, a housing and an impeller. The pump substrate has a driving unit configured to rotate the rotating shaft. The housing has an inlet and an outlet and forms a pump chamber with the pump substrate. A body fluid sucked from the inlet flows through the pump chamber. The impeller is housed in the pump chamber and is configured to use the rotating shaft as an axis. The pump substrate has a magnetism generating source. The rotating shaft protrudes into the pump chamber from the pump substrate, and is pivotally supported on the pump substrate. A magnetic fluid is disposed on at least one of spaces formed among the pump substrate, the rotating shaft, and the impeller.

The present disclosure provides a system for oxygenating blood. The system may include an implantable blood pump that may draw a supply of blood from the circulatory system of a mammalian subject, such as a human being. The blood pump may provide the supply of blood to an adaptor, where the supply of blood may be supplied to either or both of a first branch or second branch. The first branch may lead to an external blood oxygenator. The oxygenator may oxygenate the blood, and the blood may be returned to the circulatory system of the mammalian subject. The second branch may bypass the oxygenator and may connect to the circulatory system of the mammalian subject. In this regard, while the blood is supplied to the second branch, the oxygenator may be disconnected and blood may be prevented from entering the first branch.

An arrangement and a method for cardiopulmonary bypass is provided. The arrangement includes a reservoir configured to receive blood from the cardiotomy of a patient. An oxygenator receives the blood from the reservoir. An arterial connection is connected to the patient for supplying the blood from the oxygenator. A pump is provided for pumping the blood through the oxygenator to the arterial connection and the patient. The arrangement includes a supply device including a supply conduit attached to the reservoir. The supply device supplies a displacing gas to the reservoir via the supply conduit.

An extracorporeal blood circulation management device having an oxygenator accurately determines oxygen consumption by the target person and oxygen delivery by the oxygenator. Oxygenation-related parameter values in the blood are determined at regular intervals. An in-body passing time (a cycle time for a particular volume of blood to pass from input sensors to output sensors) is determined. Parameter values separated by the in-body passing time are selected as comparison targets to evaluate oxygenation consumption of the target person. An oxygenator unit passing time is determined. Parameter values separated by the oxygenator unit passing time are selected as comparison targets to evaluate oxygenation delivery of the oxygenation unit.

A transportable extracorporeal system includes a housing, a blood flow inlet, a blood flow outlet, a plurality of hollow gas permeable fibers, a gas inlet in fluid connection with inlets of the plurality of hollow gas permeable fibers, a gas outlet in fluid connection with outlets of the plurality of hollow gas permeable fibers, a first moving element, a concentrated oxygen generating device, a second moving element, a hollow transport conduit having a proximal opening and a distal opening and a power source configured to provide power to the first and second moving elements. The plurality of hollow gas permeable fibers comprising a gas transfer membrane. The concentrated oxygen generating device is configured to recycle waste oxygen from the gas transfer membrane to increase throughput and remove, by an adsorption/desorption process, unwanted gasses.

Microplegia systems describe herein use syringe pumps that are controlled in a coordinated fashion to deliver cardioplegia medications during an open-heart surgery at the prescribed dosages and/or rates. The microplegia systems link the delivery rate of the syringe pumps with the delivery rate of the cardioplegia blood flow rate. A perfusionist can enter prescribed drug concentrations, desired ratios between drug and blood, and the expected dose for each phase of the myocardial protection scheme that will take place during the open-heart surgery. Additionally, or alternatively, the syringe pump systems described herein can also be used to deliver other non-cardioplegia types of therapeutic substances

The present invention relates to systems and devices to treat and/or prevent inflammatory conditions within a subject and to related methods. More particularly, the invention relates to systems, devices, and related methods that sequester leukocytes and/or platelets and then inhibit their inflammatory action.

A control system is provided to restrict the flow rate of blood in a venous line 12 of a perfusion system 1 comprising a reservoir 10 supplied by the venous line 12 and supplying an outgoing line 22. The control system comprises an outgoing flow sensor 32 configured to determine an outgoing flow value indicative of the outgoing flow rate in the outgoing line 22, and a controller configured to process the outgoing flow value and to determine if the outgoing flow value exceeds a pre-set pairing threshold. The system further comprises an adjustable restriction 28 for restricting the flow rate in the venous line 12 to maintain a venous flow rate that does not exceed a venous restriction threshold, wherein the adjustable restriction 28 is responsive to the controller and wherein the controller comprises a configuration allowing the controller to set the adjustable restriction at the level of the outgoing flow rate, to change the venous restriction threshold with the outgoing flow rate, if the outgoing flow value is above the pre-set pairing threshold.